Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
-
Content Type
- Analyzed With
- Chemical Group
- Compounds
-
Compounds
- Instrument
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
必威体育登录手机An SEC method identifying innovator and biosimilar insulin analog was developed using an Agilent AdvanceBio SEC 130Ã…, 7.8 × 300 mm, 2.7 μm column.
- Publication Part Number: 5991-6872EN
- Created: 12 May 2021
- 513 KB
An aggregate analysis workflow for SEC mobile phase optimization and characterization of mAb aggregation profiles
- Publication Part Number: 5991-7476EN
- Created: 04 Nov 2016
- 544 KB
"This Application Note describes the quantification of aggregates in biotherapeutic
- Publication Part Number: 5991-7223EN
- Created: 01 Sep 2016
- 598 KB
必威体育登录手机Agilent AdvanceBioSEC columns used for fast, high resolution, sensitive, and reproducible separation and quantitation of mAbs and Antibody Drug Conjugate,
- Publication Part Number: 5991-7165EN
- Created: 01 Aug 2016
- 905 KB
必威体育登录手机A SEC method for determining the purity of PEG Granulocyte Colony Stimulating Factor using an Agilent AdvanceBio SEC column with aqueous mobile phase.
- Publication Part Number: 5991-6791EN
- Created: 23 Mar 2016
- 331 KB
Shorter 150 mm AdvanceBio SEC columns and higher flow rates of 1.5 mL/min increase sample throughput by 400%, from 1.3 days to under 8 hours.
- Publication Part Number: 5991-6458EN
- Created: 11 Dec 2015
- 169 KB
Analysis of an mAb (trastuzumab) and an ADC (trastuzumab emtansine) by size exclusion chromatography with online mass spectrometry (SEC-MS)
- Publication Part Number: 5991-6439EN
- Created: 01 Dec 2015
- 953 KB
High resolution and sensitive size exclusion chromatography separates and quantitates rituximab aggregates/degradants in a bioinert LC with an AdvanceBio SEC column.
- Publication Part Number: 5991-6304EN
- Created: 16 Oct 2015
- 302 KB
This Application Note shows the workflow solution for the physicochemical and biological characterization of a biosimilar and innovator rituximab.
- Publication Part Number: 5991-4920EN
- Created: 01 Aug 2014
- 2 MB
必威体育登录手机Multiple injections of Tween 20 had no effect on the performance of Agilent Bio SEC columns or integration data when analyzing IgG.
- Publication Part Number: 5991-2793EN
- Created: 18 July 2013
- 155 KB
Column choice in SEC depends on column resolving range, identified by calibration with standards appropriate to analyte type, molecular weight range, and size in solution.
- Publication Part Number: 5991-2463EN
- Created: 14 May 2013
- 117 KB
Publication Part Number | 5991-2463EN | ||||
---|---|---|---|---|---|
Analysis | Analysed with Part No. |
|
|||
Instrument |
|
||||
Analytical Technique | Technique |
|
|||
Injection |
|
||||
Detection |
|
||||
Sample | Chemical Group |
|
|||
Sample Matrix |
|
必威体育登录手机Methods are given for the use of Agilent Bio-SEC columns, with LS, UV and RI detection, for quantification or quality control of protein aggregates
- Publication Part Number: 5991-1400EN
- Created: 07 Jan 2013
- 284 KB
Publication Part Number | 5991-1400EN | ||||
---|---|---|---|---|---|
Analysis | Analysed with Part No. |
|
|||
Instrument |
|
||||
Analytical Technique | Technique |
|
|||
Injection |
|
||||
Detection |
|
||||
Sample | Chemical Group |
|
|||
Sample Matrix |
|
KM
- Publication Part Number: 5990-9894EN
- Created: 24 Feb 2012
- 666 KB
必威体育登录手机Application note for the characterization of monoclonal antibodies on the Agilent 1260 Infinity Bio-inert Quaternary LC by SEC using the Agilent BioSEC columns
- Publication Part Number: 5990-6414EN
- Created: 01 Feb 2011
- 996 KB
Publication Part Number | 5990-6414EN | ||||
---|---|---|---|---|---|
Analysis | Analysed with Part No. |
|
|||
Instrument |
|
||||
Analytical Technique | Technique |
|
|||
Injection |
|
||||
Detection |
|
||||
Sample | Chemical Group |
|
|||
Sample Matrix |
|